MEP1108A - Use of specific dose of fondaparinux sodium for the treatment of acs - Google Patents
Use of specific dose of fondaparinux sodium for the treatment of acsInfo
- Publication number
- MEP1108A MEP1108A MEP-11/08A MEP1108A MEP1108A ME P1108 A MEP1108 A ME P1108A ME P1108 A MEP1108 A ME P1108A ME P1108 A MEP1108 A ME P1108A
- Authority
- ME
- Montenegro
- Prior art keywords
- acs
- treatment
- sulfo
- specific dose
- deoxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01204323 | 2001-11-13 | ||
| PCT/EP2002/012482 WO2003041722A1 (en) | 2001-11-13 | 2002-11-07 | Use of specific dose of fondaparinux sodium for the treatment of acs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MEP1108A true MEP1108A (en) | 2011-02-10 |
Family
ID=8181220
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-2008-11A ME00229B (me) | 2001-11-13 | 2002-11-07 | Primjena specifične doze natrijum fondaparinuksa za liječenje acs |
| MEP-11/08A MEP1108A (en) | 2001-11-13 | 2002-11-07 | Use of specific dose of fondaparinux sodium for the treatment of acs |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-2008-11A ME00229B (me) | 2001-11-13 | 2002-11-07 | Primjena specifične doze natrijum fondaparinuksa za liječenje acs |
Country Status (37)
| Country | Link |
|---|---|
| US (1) | US20040248848A1 (pl) |
| EP (1) | EP1446131B1 (pl) |
| JP (1) | JP4523276B2 (pl) |
| KR (1) | KR20050044318A (pl) |
| CN (1) | CN1602197A (pl) |
| AP (1) | AP1820A (pl) |
| AR (1) | AR037291A1 (pl) |
| AT (1) | ATE361753T1 (pl) |
| AU (1) | AU2002351915B2 (pl) |
| BR (1) | BR0212915A (pl) |
| CA (1) | CA2465776A1 (pl) |
| CO (1) | CO5580790A2 (pl) |
| CY (1) | CY1106765T1 (pl) |
| DE (1) | DE60220084T2 (pl) |
| DK (1) | DK1446131T3 (pl) |
| EA (1) | EA007325B1 (pl) |
| EC (1) | ECSP045041A (pl) |
| ES (1) | ES2287343T3 (pl) |
| GE (1) | GEP20074097B (pl) |
| HK (1) | HK1070561A1 (pl) |
| HR (1) | HRP20040303B1 (pl) |
| HU (1) | HU228959B1 (pl) |
| IL (2) | IL161114A0 (pl) |
| IS (1) | IS2484B (pl) |
| MA (1) | MA27071A1 (pl) |
| ME (2) | ME00229B (pl) |
| MX (1) | MXPA04003045A (pl) |
| NO (1) | NO20041320L (pl) |
| NZ (1) | NZ552129A (pl) |
| PE (1) | PE20030740A1 (pl) |
| PL (1) | PL206008B1 (pl) |
| PT (1) | PT1446131E (pl) |
| RS (1) | RS50906B (pl) |
| SI (1) | SI1446131T1 (pl) |
| UA (1) | UA80399C2 (pl) |
| WO (1) | WO2003041722A1 (pl) |
| ZA (1) | ZA200402464B (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090075910A1 (en) * | 2007-09-13 | 2009-03-19 | Protia, Llc | Deuterium-enriched fondaparinux |
| BR112017020091A2 (pt) * | 2015-03-20 | 2018-11-06 | Aarhus Universitet | inibidores de pcsk9 para tratamento de distúrbios do metabolismo de lipoproteínas |
| US10688249B2 (en) * | 2015-06-11 | 2020-06-23 | Virchow Biotech Pvt. Ltd. | Multiple dose pharmaceutical compositions containing heparin and/or heparin-like compounds and devices and methods for delivering the same |
| CN107595769A (zh) * | 2017-10-23 | 2018-01-19 | 上海博悦生物科技有限公司 | 一种磺达肝癸钠注射液组合物的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2662442A1 (fr) * | 1990-05-23 | 1991-11-29 | Midy Spa | Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant. |
| CA2199642C (en) * | 1997-03-10 | 2001-05-08 | Roger Cariou | Compositions containing an association of aspirin and an anti-xa oligosaccharide and use of an anti-xa oligosaccharide optionally in combination with aspirin |
| FR2764511B1 (fr) * | 1997-06-13 | 2000-09-08 | Sanofi Sa | Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire |
| US20040087543A1 (en) * | 2002-04-25 | 2004-05-06 | Zachary Shriver | Methods and products for mucosal delivery |
-
2002
- 2002-07-11 UA UA2004032373A patent/UA80399C2/uk unknown
- 2002-11-07 ES ES02787601T patent/ES2287343T3/es not_active Expired - Lifetime
- 2002-11-07 WO PCT/EP2002/012482 patent/WO2003041722A1/en active IP Right Grant
- 2002-11-07 DE DE60220084T patent/DE60220084T2/de not_active Expired - Lifetime
- 2002-11-07 DK DK02787601T patent/DK1446131T3/da active
- 2002-11-07 AT AT02787601T patent/ATE361753T1/de active
- 2002-11-07 CA CA002465776A patent/CA2465776A1/en not_active Abandoned
- 2002-11-07 EP EP02787601A patent/EP1446131B1/en not_active Expired - Lifetime
- 2002-11-07 PE PE2002001086A patent/PE20030740A1/es not_active Application Discontinuation
- 2002-11-07 SI SI200230578T patent/SI1446131T1/sl unknown
- 2002-11-07 AP APAP/P/2004/003014A patent/AP1820A/en active
- 2002-11-07 MX MXPA04003045A patent/MXPA04003045A/es active IP Right Grant
- 2002-11-07 IL IL16111402A patent/IL161114A0/xx unknown
- 2002-11-07 PL PL369027A patent/PL206008B1/pl unknown
- 2002-11-07 PT PT02787601T patent/PT1446131E/pt unknown
- 2002-11-07 HU HU0401462A patent/HU228959B1/hu unknown
- 2002-11-07 JP JP2003543609A patent/JP4523276B2/ja not_active Expired - Fee Related
- 2002-11-07 US US10/492,102 patent/US20040248848A1/en not_active Abandoned
- 2002-11-07 CN CNA028192567A patent/CN1602197A/zh active Pending
- 2002-11-07 RS YUP-267/04A patent/RS50906B/sr unknown
- 2002-11-07 BR BR0212915-9A patent/BR0212915A/pt not_active Application Discontinuation
- 2002-11-07 ME MEP-2008-11A patent/ME00229B/me unknown
- 2002-11-07 AU AU2002351915A patent/AU2002351915B2/en not_active Expired
- 2002-11-07 NZ NZ552129A patent/NZ552129A/en not_active IP Right Cessation
- 2002-11-07 GE GE5516A patent/GEP20074097B/en unknown
- 2002-11-07 KR KR1020047004779A patent/KR20050044318A/ko not_active Application Discontinuation
- 2002-11-07 EA EA200400382A patent/EA007325B1/ru unknown
- 2002-11-07 ME MEP-11/08A patent/MEP1108A/xx unknown
- 2002-11-11 AR ARP020104308A patent/AR037291A1/es unknown
-
2004
- 2004-03-25 IL IL161114A patent/IL161114A/en active IP Right Grant
- 2004-03-29 ZA ZA2004/02464A patent/ZA200402464B/en unknown
- 2004-03-29 IS IS7199A patent/IS2484B/is unknown
- 2004-03-30 NO NO20041320A patent/NO20041320L/no not_active Application Discontinuation
- 2004-03-30 HR HR20040303A patent/HRP20040303B1/xx not_active IP Right Cessation
- 2004-03-31 MA MA27602A patent/MA27071A1/fr unknown
- 2004-03-31 EC EC2004005041A patent/ECSP045041A/es unknown
- 2004-03-31 CO CO04030711A patent/CO5580790A2/es not_active Application Discontinuation
-
2005
- 2005-02-08 HK HK05101101A patent/HK1070561A1/xx not_active IP Right Cessation
-
2007
- 2007-07-30 CY CY20071101000T patent/CY1106765T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2190075T3 (es) | Formulaciones farmaceuticas solidas que contienen una mezcla fisica de sulfoalquil-eter-ciclodextrina y un agente terapeutico. | |
| NO20011721D0 (no) | N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor | |
| PT975235E (pt) | Formulacoes nutricionais contendo oligossacaridos | |
| MEP10408A (en) | Platinum derivative pharmaceutical formulations | |
| AR035711A1 (es) | Prodrogas 3' de 2'-desoxi-beta-l-nucleosidos; sus composiciones farmaceuticas; metodo para el tratamiento o profilaxis de una infeccion del virus de la hepatitis b y sus usos para la manufactura de composiciones farmaceuticas | |
| AP2002002674A0 (en) | Clear Aqueous Anaesthetic composition. | |
| DK0538011T3 (da) | Saltsammensætninger omfattende lipofilt oligosaccharidantibiotikum. | |
| PT1272199E (pt) | Terapias de combinacao com actividade de lesao vascular | |
| NO994431L (no) | Ny formulering | |
| ID28510A (id) | Formulasi oral yang baru untuk agonis atau antagonis 5-ht4 | |
| MEP1108A (en) | Use of specific dose of fondaparinux sodium for the treatment of acs | |
| ES2176009T3 (es) | Utilizacion de cloruro de sodio para reducir la toxicidad gastrointestinal de los derivados de la competencia. | |
| BRPI9916820B8 (pt) | composição compreendendo 9[2[[bis[(pivaloilóxi)metil]fosfono]metóxi]etil]adenina, comprimido ou cápsula e método | |
| DK0875248T3 (da) | Anvendelse af hyaluronsyre og korresponderende salte til fremstilling af en vandig opløsning, der er velegnet som intra-artikulær skyllevæske | |
| ES2197781A1 (es) | Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno. | |
| YU87501A (sh) | Farmaceutski kompleksi | |
| EP1411956B8 (en) | Use of oversulfated polysaccharides as inhibitors of hiv | |
| JP2005509007A5 (pl) | ||
| FR2797446B1 (fr) | Derives de phenanthroline-7-ones et leurs applications en therapeutique | |
| JP2005519919A5 (pl) | ||
| BR0307196A (pt) | Idraparinux (sanorg 34006) para tratamento e profilaxia secundária de eventos tromboembólicos venosos em pacientes com trombose venosa profunda | |
| EA199800848A1 (ru) | Гиполипидемическое и антиатеросклеротическое средство | |
| EP1547603A3 (en) | Compositions and methods for use in targeting vascular destruction | |
| IT1190961B (it) | Derivati dell'acido lattobionico,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono |